相关实验视频
Updated: Jun 26, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
开发个性化策略,精确打击恶性黑色素瘤
Armond J Isaak1, GeGe R Clements1, Rand Gabriel M Buenaventura1
1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
International journal of molecular sciences
|May 11, 2024
概括
黑色素瘤是一种致命的皮肤癌,由于耐药性和毒性,它存在治疗挑战. 本综述探讨了标准疗法和新兴的个性化瘤学策略,以克服这些障碍.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 遗传学 是一个遗传学.
背景情况:
- 黑色素瘤是一种严重的皮肤癌,具有显著的分子异质性.
- 标准治疗方法,如免疫检查点抑制剂和向疗法,用于晚期黑色素瘤.
- 耐药性和毒性限制了当前黑色素瘤治疗的有效性.
研究的目的:
- 审查目前标准黑色素瘤治疗的现状.
- 探索针对黑色素瘤治疗的个性化瘤技术.
- 总结了克服黑色素瘤管理障碍的工具.
主要方法:
- 关于标准黑色素瘤疗法的文献综述.
- 探索个性化的瘤学方法.
- 综合当前关于黑色素瘤治疗策略的研究.
主要成果:
- 标准疗法 (免疫检查点抑制剂,向疗法) 有局限性.
- 获得的耐药性和毒性是重大挑战.
- 个性化瘤学提供了潜在的新战略.
结论:
- 需要新的策略来解决黑色素瘤的耐药性和毒性问题.
- 个性化瘤学有望为量身定制的黑色素瘤治疗提供希望.
- 对现有工具的最新理解对于有效的黑色素瘤管理至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

